Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.10.2 (
focal adhesion kinase
)
44,029
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Nucleoporin 214 (
NUP214)
, previously termed
CAN,
is required for cell cycle and nucleocytoplasmic transport. The genetic features and clinical implications of five
NUP214
-associated fusion genes are described in this review.
SET-NUP214
was most frequently observed in T-cell acute lymphoblastic leukemia (T-ALL), concomitant with the elevated expression of
HOXA
cluster genes. Furthermore, the fusion transcript may be regarded as a potential minimal residual disease marker for
SET-NUP214
-positive patients. Episomal amplifications of
NUP214-
ABL1
are specific to T-ALL patients. The
NUP214-
ABL1
gene is observed in ~6% of T-ALL, in children and adults. Targeted tyrosine kinase inhibitors plus standard chemotherapy appear to present a promising treatment strategy.
DEK-NUP214
is formed by the fusion of exon 2 of
DEK
and exon 6 of
NUP214
. Achieving molecular negativity of
DEK-NUP214
is of great importance for individual management.
SQSTM1-NUP214
and
NUP214-
XKR3
were only identified in one T-ALL patient and one cell line, respectively. The
NUP214
fusions have significant diagnostic and therapeutic implications for leukemia patients. Additional
NUP214
-associated fusions require identification in future studies.
...
PMID:
NUP214
fusion genes in acute leukemia (Review). 2512 Jun 41